Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Cryopreserved Platelets: From in Vitro Thrombin Generation Potential to in Vivo Safety

Mariasanta Napolitano, MDPhD, Lucio Lo Coco, PhD, Giorgia Saccullo, MD, Piera Stefania Arfò, PhD, Giuseppe Tarantino, MD, Claudia Di Gesù, PhD, Ivan Noel Sciortino, PhD, Amalia Reina, PhD, Giovanni De Francisci, MD, Rosalia Agliastro, MD, Sergio Siragusa, MD

Blood (2015) 126 (23): 2339.

https://doi.org/10.1182/blood.V126.23.2339.2339

Published: 2015

Journal Articles

Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System

Mariasanta Napolitano, MD, Lucio Lo Coco, Giorgia Saccullo, MD, Giovanni De Francisci, MD, Amalia Reina, PhD, Debora Allegro, PhD, Raffaella Fadda, MD, Diana Di Liberto, PhD, Salvatrice Mancuso, MD, Luca Valore, MD, Gianpaolo Vaccarella, Rosalia Agliastro, MD, Francesco Dieli, Sergio Siragusa, MD

Blood (2013) 122 (21): 1158.

https://doi.org/10.1182/blood.V122.21.1158.1158

Published: 2013

Journal Articles

Cancer Patients Requiring Interruption of Long-Term Anticoagulant Therapy: The Use of Fixed Sub-Therapeutic Doses of Low-Molecular Weight Heparin

Giorgia Saccullo, Alessandra Malato, Lucio Lo Coco, Ilenia Barbello, Clementina Caracciolo, Simona Raso, Marco Santoro, Orazio Graziano Di Bartolo, Ambra Di Piazza, Vincenzo Abbadessa, Sergio Siragusa, MD

Blood (2011) 118 (21): 1244.

https://doi.org/10.1182/blood.V118.21.1244.1244

Published: 2011

Journal Articles

The Optimal Duration of Anticoagulant Therapy In Patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study)

Blood (2010) 116 (21): 190.

https://doi.org/10.1182/blood.V116.21.190.190

Published: 2010

Journal Articles

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis.

Sergio Siragusa, MD, Alessandra Malato, MD, Fabio Fulfaro, Giorgia Saccullo, Domenica Caramazza, Giusy Pizzo, Lucio lo Coco, Nicola Gebbia

Blood (2009) 114 (22): 3999.

https://doi.org/10.1182/blood.V114.22.3999.3999

Published: 2009

Journal Articles

Polycythemia Vera as a Predisposing Factor for Aortic Stenosis: Prevalence and Correlation with Blood Cells Count and Mutational Status

Ri ta Barone, Clementina Caracciolo, Rosario di Maggio, Giovanni Fazio, Luciana d’Angelo, Maria Montana, Salvatore Novo, Lucio lo Coco, Domenica Caramazza, Vincenzo Abbadessa, Sergio Siragusa, MD

Blood (2008) 112 (11): 5247.

https://doi.org/10.1182/blood.V112.11.5247.5247

Published: 2008

Journal Articles

Absence of Residual Vein Thrombosis after an Episode of Idiopathic Deep Vein Thrombosis: Short-Term Anticoagulation Is Safe. The “Extended Dacus Study”.

Sergio M. Siragusa, MD, Alessandra Malato, MD, Mario Bellisi, MD, Maria Teresa Attanzio, MD, Valeria Cigna, MD, Domenica Caramazza, MD, Lucio Lo Coco, Glauco Milio, MD, Guido Bajardi, MD

Blood (2007) 110 (11): 301.

https://doi.org/10.1182/blood.V110.11.301.301

Published: 2007

Journal Articles

Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer.

Sergio Siragusa, MD, Alessandra Malato, MD, Fabio Fulfaro, MD, Domenica Caramazza, MD, Lucio Lo Coco, MD, Raffaela Anastasio, MD, Nicola Gebbia, MD

Blood (2007) 110 (11): 699.

https://doi.org/10.1182/blood.V110.11.699.699

Published: 2007

Journal Articles

The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease.

Sergio Siragusa, MD, Alessandra Malato, MD, Raffaela Anastasio, MD, Ignazio Abbene, Carlo Arcara, MD, Lucio Lo Coco, Alessandra Casuccio, MD

Blood (2005) 106 (11): 262.

https://doi.org/10.1182/blood.V106.11.262.262

Published: 2005

Journal Articles

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk.

Sergio Siragusa, MD, Alessandra Malato, MD, Antonino Giarratano, MD, Francesco Falaschi, MD, Fernando Porro, MD, Maria Cristina Buonanno, MD, Elena Maggi, MD, Raffaela Anastasio, MD, Lucio Lo Coco, Guglielmo Mariani, MD

Blood (2005) 106 (11): 1628.

https://doi.org/10.1182/blood.V106.11.1628.1628

Published: 2005

NARROW

Cryopreserved Platelets: From in Vitro Thrombin Generation Potential to in Vivo Safety

Functional In Vitro Studies Of Buffy Coat Pooled Platelets Cryopreserved In Dimethyl-Sulphoxide With a New System

Cancer Patients Requiring Interruption of Long-Term Anticoagulant Therapy: The Use of Fixed Sub-Therapeutic Doses of Low-Molecular Weight Heparin

The Optimal Duration of Anticoagulant Therapy In Patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study)

Residual Vein Thrombosis Improves Screening for Occult Cancer: Results On 537 Patients with Idiopathic Deep Vein Thrombosis.

Polycythemia Vera as a Predisposing Factor for Aortic Stenosis: Prevalence and Correlation with Blood Cells Count and Mutational Status

Absence of Residual Vein Thrombosis after an Episode of Idiopathic Deep Vein Thrombosis: Short-Term Anticoagulation Is Safe. The “Extended Dacus Study”.

Cancer-Related Venous Thrombosis: Residual Vein Thrombosis Improves Screening for Occult Cancer.

The Persistance of Residual Vein Thrombosis, after an Episode of Deep Vein Thrombosis, and the Risk of New Overt Cancer and Cardiovascular Disease.

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only